Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?

Key TakeawaysLLY has declined 10.6% this month after disappointing third-quarter results.The drug maker has seen strong success in recent years, with several new drugs in the pipeline.Register now to see our 7 Best Stocks for the Next 30 Days report - free today!The stock of Eli Lilly and Company (LLY) has declined 10.6% in a month. On Oct. 30, Lilly announced disappointing third-quarter 2024 results as it missed estimates for earnings as well as sales and also lowered its financial guidance for the year. S ...